References
- Kroto HW, Heath JR, O'Brien SC, Curl RF, Smalley RE. C60: Buckminsterfullerene. Nature 1985;318:162–163.
- Hu Z, Guan W, Wang W, Huang L, Xing H, Zhu Z. Protective effect of a novel cystine C60 derivative on hydrogen peroxide-induced apoptosis in rat pheochromocytoma PC12 cells. Chem Biol Interact 2007;167:135–144.
- Friedman SH, DeCamp DL, Sijbesma RP, Srdanov G, Wudl F, Kenyon GL. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J Am Chem Soc 1993;115:6506–6509.
- Tokuyama H, Yamago S, Nakamura E, Shiraki T, Sugiura Y. Photoinduced biochemical activity of fullerene carboxylic acid. J Am Chem Soc 1993;115:7918–7919.
- Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, Bonn GK. Medicinal applications of fullerene. Int J Nanomedicine 2007;2:639–649.
- Bosi S, Da Ros T, Spalluto G, Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 2003;38:913–923.
- Mashino T, Nishikawa D, Takahashi K, Usui N, Yamori T, Seki M, Endo T, Mochizuki M. Antibacterial and antiproliferative activity of cationic fullerene derivatives. Bioorg Med Chem Lett 2003;13:4395–4397.
- Okuda K, Mashino T, Hirobe M. Superoxide radical quenching and cytochrome c peroxidase-like activity of C60-dimalonic acid, C62(COOH)4. Bioorg Med Chem Lett 1996;6:539–542.
- Mashino T, Shimotohno K, Ikegami N, Nishikawa D, Okuda K, Takahashi K, Nakamura S, Mochizuki M. Human immunodeficiency virus-reversetranscriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition antivities of fullerene derivatives. Bioorg Med Chem Lett 2005;15:1107–1109.
- Sayes CM, Gobin AM, Ausman KD, Mendez J, WestJL, Colvin VL. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 2005;26:7587–7595.
- Yamawaki H, Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 2006;290:C1495–C1502.
- Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, Dramicanin M, Harhaji L, Raicevic N, Nikolic Z, Trajkovic V. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006;91:173–183.
- Mashino T, Usui N, Okuda K, Hirota T, Mochizuki M. Respiratory chain inhibition by fullerene derivatives: hydrogen peroxide production caused by fullerene derivatives and a respiratory chain system. Bioorg Med Chem 2003;11:1433–1438.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
- Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312–1316.
- Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999;11:255–260.
- Thorburn A. Death receptor-induced cell killing. Cell Signal 2004;16:139–144.
- Negre-Salvayre A, Augé N, Duval C, Robbesyn F, Thiers JC, Nazzal D, Benoist H, Salvayre R. Detection of intracellular reactive oxygen species in cultured cells using fluorescent probes. Methods Enzymol 2002;352:62–71.
- Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, Larroque C. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 2002;294:116–119.
- Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rdNew York: Oxford University Press; 1999.
- Petak I, Houghton JA. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res 2001;7:95–106.
- Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. Cancer Chemother Pharmacol 2002;50:343–352.
- Wan CK, Wang C, Cheung1 HY, Yang M, Fong WF. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells. Cancer Lett 2006;241:31–41.
- Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA. p53-dependent ceramide response to genotoxic stress. J Clin Invest 1998;102:329–339.